October 27, 2016 01:59 PM EDT
R&D

Bil­lion­aire Be­zos, Arch car­ry a torch for ag­ing R&D, back $116M mega-round for Uni­ty

John Carroll

Editor & Founder

Ag­ing R&D is get­ting a big boost to­day.

Jeff Be­zos, Arch and oth­er in­vestors drawn to the field have put to­geth­er a $116 mil­lion mega …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times